Archives

by in
Entry Author Date Location
East Coast Life Sciences Roundup: Selecta, Rib-X, Cambridge, & More 11/30/12 Boston
Rib-X Closes First Tranche of $67.5 Million Preferred Stock Financing 11/29/12 Boston
Rib-X Pharmaceuticals Lands Series B Financing Round 11/29/12 Boston
Genzyme, Epizyme, & Rib-X Among the Week’s Life Sciences Newsmakers 04/27/12 Boston
Rib-X, Skyhook, Michael J. Fox Foundation & More Boston-Area Deals News 11/30/11 Boston
Rib-X Pharma Files for IPO 11/28/11 Boston
Rib-X Inks Sanofi Deal, Zafgen Gets $33M Series C, Allegro Adds $5.4M, & More Boston-Area Life Sciences News 07/08/11 Boston
Rib-X Inks Research Agreement With Sanofi 07/06/11 Boston
Rib-X Pharmaceuticals Garners $5,500,000 New Round 01/28/11 Boston
Rib-X Wrappes Up $20M, Oxford Closes $66M on Sixth Fund, Ocular Adds $6M, & More Boston-Area Life Sciences News 01/14/11 Boston
Rib-X Raises Another $20M, Led by Warburg Pincus, to Develop Late Stage Antibiotics 01/11/11 Boston
Rib-X Pharmaceuticals Receives $20,000,000 New Financing Round 01/11/11 Boston
Rib-X Adds $5.5M Debt 06/11/10 Boston
Former Targanta CEO Leuchtenberger Lands New Gig at Rib-X, Another Antibiotic Company 03/23/10 Boston
Rib-X Maps Out Pivotal Antibiotic Trial, As Part of Built-to-Last Company Strategy 02/16/10 Boston
Rib-X Founder Gets Nobel Prize 10/07/09 Boston
Rib-X Antibiotic Passes Clinical Trial, Hopes to Snag Partner 08/05/09 Boston
Rib-X Pharmaceuticals Inc. Lands $25,000,000 Series D Round 02/04/09 Boston
Rib-X Raises $25M in Debt Financing, Reveals Final Results of Antibiotic Trial 01/26/09 Boston
Rib-X Pharmaceuticals Inc. Garners $25,000,000 New Funding 01/26/09 Boston
Rib-X Reveals “Positive” Antibiotic Data 12/08/08 Boston
Rib-X Pharma, and Its Lead Antibiotic, Gear Up for Prime Time 10/02/08 Boston
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More 02/14/14 Boston
Athenahealth, iRobot, PerkinElmer, & More in Boston Life Sciences News 09/14/12 Boston
Gladstone, Sage Bionetworks Top ‘Best Places to Work’ List 08/01/12 National
Boston Life Sciences News From Vertex, Eleven, RXi, & More 05/11/12 Boston
Antibiotic R&D is in Trouble: Here’s One Way to Fix It 05/07/12 National
Biotech IPOs Start to Show Some Modest Signs of Life 04/30/12 National
Infinity, Idera, Civitas, & More Boston-Area Life Sciences Headlines 12/02/11 Boston
Venture Investment in New England Companies Is Down from a Year Ago; Here Are the Top 10 Deals from the First Quarter 04/15/11 Boston
Page 1 of 2 next page »